Home Authors Posts by Tess Egginton

Tess Egginton

Tess Egginton
1447 POSTS 0 COMMENTS
http://www.pbiforum.net

Pfizer completes acquisition of Biohaven Pharmaceuticals

Aspire Pharma acquires Morningside Pharmaceuticals

Ventus Therapeutics enters exclusive development and license agreement with Novo Nordisk...

FDA approves Amylyx Pharmaceuticals’ RELYVRIO to treat ALS

Scribe Therapeutics reveals research collaboration with Sanofi to accelerate breakthrough CRISPR-based...

Koselugo approved in Japan for paediatric patients with plexiform neurofibromas in...

Tezspire approved in Japan for the treatment of severe asthma

ACG appoints Shankar Gupta as chief sales officer

Canada

Bausch Health and Glenmark’s RYALTRIS approved in Canada for seasonal allergic...

Ultomiris approved in Europe for the treatment of adults with generalised...

1...109110111...145Page 110 of 145

News

AstraZeneca to acquire EsoBiotec in $1bn deal

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical...
Canada

SKYCLARYS approved by Health Canada for Friedreich’s ataxia

Health Canada has approved Biogen's SKYCLARYS (omaveloxolone) for the treatment of Friedreich’s ataxia (FA) in patients 16 years of age and older. This approval...

Maxion Therapeutics raises $72m in oversubscribed Series A financing to advance KnotBody pipeline and...

Maxion Therapeutics, a biotechnology company developing antibody-based KnotBody drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases, has raised $72 million in...

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks